Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2002-10-03
2009-12-29
Epps-Smith, Janet (Department: 1633)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S069100, C435S325000, C530S351000, C424S085400, C424S192100
Reexamination Certificate
active
07638304
ABSTRACT:
New hybrid or chimeric fusion polypeptide transcription regulators which induce interferon target gene expression are provided for use in anti-viral and anti-proliferative applications. The hybrid fusion proteins comprise the p48 interferon regulatory factor protein, or a functional portion thereof, fused to a transcriptional activation domain (TAD), or a functional portion thereof. More specifically, the p48 interferon regulatory factor protein is fused to a STAT transcriptional activation do main (TAD) (p48-STAT TAD). A particular p48-STAT TAD is p48-S2C, in which S2C is the TAD of STAT2. Another p48-TAD is p48-VP16 TAD, in which p48 is fused to the transcriptional activation domain of the VP16 protein of Herpes Simplex Virus (HSV). The p48-TAD nucleic acid sequences and encoded polypeptides can be employed for anti-viral treatment and for the treatment of cancers, tumors and neoplastic diseases.
REFERENCES:
patent: 6087478 (2000-07-01), Vinkemeier
patent: 6348586 (2002-02-01), Chang et al.
patent: 7087726 (2006-08-01), Chuntharapai et al.
patent: WO 02/068614 (2002-09-01), None
Lin (1994) J. Biol. Chem. 269:17542-17549.
Schang (2002) J. Antimicrob. Chemother. 50:779-792.
Andrei (2006) Antivir. Res. 71:96-107.
Kraus et al. (2003) J. Biol. Chem. 278:13033-13038.
Honda et al. (2006) Nat. Rev. Immunol. 6:644-658.
Tanaka et al. (2000) Seminars Cancer Biol. 10:73-81.
Torchilin et al. (2003) DDT 8:259-266.
Wei-Chu Au et al. Identification Of A Member Of The Interferon Regulatory Factor Family That Binds To The Interferon-stimulated Response Element And Activates Expression Of Interferon-induced GenesPro.Nat'l. Acad. Sci. USA, vol. 92 pp. 11657-11661, Dec. 1995.
Hans A. R. Bluyssen et al., “Stat2 Is A Transcriptional Activator That Requires Sequence-specific Contacts Provided By Statl and p48 for Stable Interaction With DNA”The Journal Of Biological Chemistry, vol. 272, No. 7 pp. 4600-4605, Feb. 14, 1997.
Horvath Curt M.
Lau Joe F.
Epps-Smith Janet
Locke Lord Bissell & Liddell LLP
Mount Sinai School of Medicine of New York University
Schurter Brandon T.
LandOfFree
Hybrid fusion protein transcription regulator to induce... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid fusion protein transcription regulator to induce..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid fusion protein transcription regulator to induce... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4109940